- Record: found
- Abstract: not found
- Article: not found
NGM313, a novel once-monthly activator of β-Klotho/FGFR1c, significantly reduces hepatic steatosis and key biomarkers of nonalcoholic steatohepatitis: results of a randomized, active-controlled clamp study in obese insulin resistant patients with NAFLD
A. DePaoli, S Shankar, M.R. Bashir, B.A. Baxter, V. Phung, A.Z. Yan, DePaoli, MR Bashir, BA Baxter, AZ Yan, SJ Rossi, AM DePaoli, M. H Bashir, B. Timothy Baxter, A. T. Yan, S. Rossi
2018
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.